Impact of Pharmaceutical Prophylaxis on Radiation-Induced Liver Disease Following Radioembolization
Authors:
- Max SeidenstickerMSMax Seidensticker
- Matthias Philipp FabritiusMFMatthias Philipp Fabritius
- Jannik BellerJBJannik Beller
- Ricarda SeidenstickerRSRicarda Seidensticker
- Andrei TodicaATAndrei Todica
- Harun IlhanHIHarun Ilhan
- Maciej PechMPMaciej Pech
- Constanze HeinzeCHConstanze Heinze
- Maciej PowerskiMPMaciej Powerski
- Robert DammRDRobert Damm
- Alexander WeissAWAlexander Weiss
- Johannes RueckelJRJohannes Rueckel
Open Access
Abstract
Background: Radioembolization (RE) with yttrium-90 (90Y) resin microspheres yields heterogeneous response rates in with primary or secondary liver cancer. Radiation-induced liver disease (RILD) is a potentially life-threatening complication with higher prevalence in cirrhotics or patients exposed to previous chemotherapies. Advances in RILD prevention may help increasing tolerable radiation doses to improve patient outcomes. This study aimed to evaluate the impact of post-therapeutic RILD-prophylaxis in a cohort of intensely pretreated liver metastatic breast cancer patients; Methods: Ninety-three patients with liver metastases of breast cancer received RE between 2007 and 2016. All Patients received RILD prophylaxis for 8 weeks post-RE. From January 2014, RILD prophylaxis was changed from ursodeoxycholic acid (UDCA) and prednisolone (standard prophylaxis [SP]; n = 59) to pentoxifylline (PTX), UDCA and low-dose low molecular weight heparin (LMWH) (modified prophylaxis (MP); n = 34). The primary endpoint was toxicity including symptoms of RILD; Results: Dose exposure of normal liver parenchyma was higher in the modified vs. standard prophylaxis group (47.2 Gy (17.8–86.8) vs. 40.2 Gy (12.5–83.5), p = 0.017). All grade RILD events (mild: bilirubin ≥ 21 µmol/L (but 0.1). ALBI grade increased in 16.7% patients in the MP and in 27.1% patients in the SP group, respectively (group difference not significant); Conclusions: At established dose levels, mild or severe RILD events proved rare in our cohort. RILD prophylaxis with PTX, UDCA and LMWH appears to have an independent positive impact on OS in patients with metastatic breast cancer and may reduce the frequency and severity of RILD. Results of this study as well as pathophysiological considerations warrant further investigations of RILD prophylaxis presumably targeting combinations of anticoagulation (MP) and antiinflammation (SP) to increase dose prescriptions in radioembolization.Keywords
This publication has 43 references indexed in Scilit:
- Prognostic factors and prevention of radioembolization-induced liver diseaseHepatology, 2012
- Toxicities after Radioembolization with Yttrium-90 SIR-Spheres: Incidence and Contributing Risk Factors at a Single CenterJournal of Vascular and Interventional Radiology, 2011
- Radioembolization Results in Longer Time-to-Progression and Reduced Toxicity Compared With Chemoembolization in Patients With Hepatocellular CarcinomaGastroenterology, 2011
- Treatment Parameters and Outcome in 680 Treatments of Internal Radiation With Resin 90Y-Microspheres for Unresectable Hepatic TumorsInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2009
- Liver disease induced by radioembolization of liver tumorsCancer, 2008
- In vivo assessment of the tolerance dose of small liver volumes after single-fraction HDR irradiationInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2005
- The Japanese multicenter open randomized trial of ursodeoxycholic acid prophylaxis for hepatic veno-occlusive disease after stem cell transplantationAmerican Journal of Hematology, 2000
- Hepatic toxicity resulting from cancer treatmentInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1995
- Accelerated hyperfractionated hepatic irradiation in the management of patients with liver metastases: Results of the rtog dose escalating protocolInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1993
- Tolerance of normal tissue to therapeutic irradiationInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1991